Page last updated: 2024-10-15
dinactin
Description
dinactin: homolog of the above minor; a macrotetrolide [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
ID Source | ID |
PubMed CID | 156588868 |
MeSH ID | M0066566 |
Synonyms (4)
Synonym |
NSC63925 , |
20261-85-2 |
dinactin |
HY-121333 |
Dosage Studied
Excerpt | Reference |
" Dinactin inhibited T-cell proliferation induced by IL-2, by mAb to CD3, and by mAbs to CD3 plus alpha-CD28 with identical dose-response curves (IC50 = 10-20 ng/ml)." | ( Effects of cyclosporin A and dinactin on T-cell proliferation, interleukin-5 production, and murine pulmonary inflammation. Egan, RW; Falcone, A; Garlisi, CG; Hegde, V; Jakway, JP; Kung, TT; Motasim Billah, M; Patel, M; Razac, S; Shah, H; Shortall, J; Stelts, D; Umland, SP, 1999) |
Research
Studies (15)
Timeframe | Studies, This Drug (%) | All Drugs % |
pre-1990 | 4 (26.67) | 18.7374 |
1990's | 4 (26.67) | 18.2507 |
2000's | 2 (13.33) | 29.6817 |
2010's | 4 (26.67) | 24.3611 |
2020's | 1 (6.67) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Study Types
Publication Type | This drug (%) | All Drugs (%) |
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 16 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |